Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Hall

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|February 27, 2007
Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarctionXiaoli Liu, Jeremy A Simpson, Keith R Brunt, et al.
Clinical and Translational Medicine|March 31, 2025
Transitional CXCL14<sup>+</sup> cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinomaWeijiao Xu, Haitang Yang, Ke Xu, et al.
International Journal of Molecular Sciences|August 14, 2025
Feasibility of Manufacturing and Antitumor Activity of TIL for Advanced Endometrial CancersYongliang Zhang, Kathleen N Moore, Amir A Jazaeri, et al.
Oncoimmunology|February 14, 2022
Functional and molecular characterization of PD1<sup>+</sup> tumor-infiltrating lymphocytes from lung cancer patientsJesse J Lipp, Limei Wang, Haitang Yang, et al.
Stem Cells and Development|March 7, 2015
Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responsesEmmy L D de Mare-Bredemeijer, Shanta Mancham, Monique M A Verstegen, et al.
Cell Death Discovery|February 10, 2023
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesotheliomaHaitang Yang, Yanyun Gao, Duo Xu, et al.
Oncogene|September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancerShun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.
Plos Pathogens|July 28, 2021
Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infectionMelanie Brügger, Thomas Démoulins, G Tuba Barut, et al.
The Journal of Urology|April 1, 1996
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow upD A Tolley, M K Parmar, K M Grigor, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 20, 2020
CD90<sup>+</sup>CD146<sup>+</sup> identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lungLimei Wang, Patrick Dorn, Soheila Zeinali, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
American Journal of Physiology. Heart and Circulatory Physiology|February 27, 2007
Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarctionXiaoli Liu, Jeremy A Simpson, Keith R Brunt, et al.
Clinical and Translational Medicine|March 31, 2025
Transitional CXCL14<sup>+</sup> cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinomaWeijiao Xu, Haitang Yang, Ke Xu, et al.
International Journal of Molecular Sciences|August 14, 2025
Feasibility of Manufacturing and Antitumor Activity of TIL for Advanced Endometrial CancersYongliang Zhang, Kathleen N Moore, Amir A Jazaeri, et al.
Oncoimmunology|February 14, 2022
Functional and molecular characterization of PD1<sup>+</sup> tumor-infiltrating lymphocytes from lung cancer patientsJesse J Lipp, Limei Wang, Haitang Yang, et al.
Stem Cells and Development|March 7, 2015
Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responsesEmmy L D de Mare-Bredemeijer, Shanta Mancham, Monique M A Verstegen, et al.
Cell Death Discovery|February 10, 2023
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesotheliomaHaitang Yang, Yanyun Gao, Duo Xu, et al.
Oncogene|September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancerShun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.
Plos Pathogens|July 28, 2021
Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infectionMelanie Brügger, Thomas Démoulins, G Tuba Barut, et al.
The Journal of Urology|April 1, 1996
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow upD A Tolley, M K Parmar, K M Grigor, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 20, 2020
CD90<sup>+</sup>CD146<sup>+</sup> identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lungLimei Wang, Patrick Dorn, Soheila Zeinali, et al.
Pageof 16